title: A comparative study of the usefulness of color vision, photostress recovery time, and visual evoked potential tests in early detection of ocular toxicity from hydroxychloroquine.
abstract: Ocular toxicity from hydroxychloroquine (HCQ) is rare, but its potential permanence and severity makes it imperative to employ measures and screening protocols to minimize its occurrence. This study was performed to assess the usefulness of color vision, photo stress recovery time (PSRT), and visual evoked potentials (VEP) in early detection of ocular toxicity of HCQ, in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). 86 patients were included in the study and divided into three groups: (1) with history of HCQ use: interventional 1 (Int.1) without fundoscopic changes and Int.2 with fundoscopic changes; and (2) without history of HCQ use, as control. Visual field, color vision, PSRT and VEP results were recorded for all patients and the effect of age, disease duration, treatment duration and cumulative dose of HCQ on each test was assessed in each group. There was a significant relationship among PSRT and age, treatment duration, cumulative dose of HCQ and disease duration (P<0.001 for all). Color vision was normal in all the cases. P100 amplitude was not different between the three groups (P=0.846), but P100 latency was significantly different (P=0.025) and for Int.2 it was greater than the others. The percentage of abnormal visual fields for Int.2 was more than Int.1 and control groups (P=0.002 and P=0.005 respectively), but Int.1 and control groups were not significantly different (P>0.50). In the early stages of maculopathy, P100 latencies of VEP and PSRT are useful predictors of HCQ ocular toxicity. In patients without ocular symptoms and fundoscopic changes, the P100 latency of VEP predicts more precisely than the others.
authors: Paramedical College, Mashhad University of Medical Sciences, Mashhad, Iran.
authors: Javad
authors: J
authors: Heravian
authors: Massoud
authors: M
authors: Saghafi
authors: Naser
authors: N
authors: Shoeibi
authors: Samira
authors: S
authors: Hassanzadeh
authors: Mohammad Taghi
authors: MT
authors: Shakeri
authors: Maria
authors: M
authors: Sharepoor
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D055253:Color Vision / Q000187:drug effects*; D042241:Early Diagnosis; D005074:Evoked Potentials, Visual / Q000187:drug effects*; D005128:Eye Diseases / Q000139:chemically induced / Q000175:diagnosis* / Q000503:physiopathology; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012307:Risk Factors; D014787:Vision Tests; D014794:Visual Fields / Q000187:drug effects; D055815:Young Adult
chemical_list: D018501:Antirheumatic Agents; D006886:Hydroxychloroquine